WP2 - Constitution of a European Hematological/NGS platform

The overall objective of WP2 is to benefit from the synergistic value offered by different national leukemia study groups and their interdisciplinary partners to constitute a European network on NGS.

Moreover, WP2 is devoted to the identification of clinical and molecular inclusion criteria for the selection of leukemia patients to be involved in the project, as well as to the definition of the collection of Omic analyses to be applied.